Abstract
Type II diabetes mellitus is one of major lifestyle disorders worldwide. Despite numerous therapeutic interventions, cases and adverse health effects are still rising. Many plant substances, known as phytochemicals, display potential to treat diabetes, yet their clinical application is actually limited by inefficient delivery. In this review, we show that recent nano-delivery systems such as liposomes, niosomes, solid–liquid nanoparticles, nanostructured lipid carriers, nanomicelles and nanoparticles improve pharmacokinetic properties of entrapped phytochemicals for the treatment of diabetes and associated vascular complications.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aba P, Asuzu I (2018) Mechanisms of actions of some bioactive anti-diabetic principles from phytochemicals of medicinal plants: a review. Indian J Nat Prod Resour 9:85–96
Abdel-Mageid A, Abou-Salem M, Salaam N, El-Garhy H (2018) The potential effect of garlic extract and curcumin nanoparticles against complication accompanied with experimentally induced diabetes in rats. Phytomedicine 43:126–134. https://doi.org/10.1016/j.phymed.2018.04.039
Acharjee S, Ghosh B, Al-Dhubiab B, Nair A (2013) Understanding type I diabetes: etiology and models. Can J Diabetes 37:269–276. https://doi.org/10.1016/j.jcjd.2013.05.001
Ahangarpour A, Oroojan A, Khorsandi L, Kouchak M, Badavi M (2018) Solid lipid nanoparticles of myricitrin have antioxidant and antidiabetic effects on streptozotocin-nicotinamide-induced diabetic model and myotube cell of male mouse. Oxid Med Cell Longev 2018:1–18. https://doi.org/10.1155/2018/7496936
Ahmad Z, Shah A, Siddiq M, Kraatz H (2014) Polymeric micelles as drug delivery vehicles. RSC Adv 4:17028–17038. https://doi.org/10.1039/c3ra47370h
Akbar M, Zia K, Akash M, Nazir A, Zuber M, Ibrahim M (2018) In-vivo anti-diabetic and wound healing potential of chitosan/alginate/maltodextrin/pluronic-based mixed polymeric micelles: curcumin therapeutic potential. Int J Biol Macromol 120:2418–2430. https://doi.org/10.1016/j.ijbiomac.2018.09.010
Amanat S, Taymouri S, Varshosaz J, Minaiyan M, Talebi A (2020) Carboxymethyl cellulose-based wafer enriched with resveratrol-loaded nanoparticles for enhanced wound healing. Drug Deliv Transl Res 10:1241–1254. https://doi.org/10.1007/s13346-020-00711-w
Amjadi S, Mesgari Abbasi M, Shokouhi B, Ghorbani M, Hamishehkar H (2019) Enhancement of therapeutic efficacy of betanin for diabetes treatment by liposomal nanocarriers. J Funct Foods 59:119–128. https://doi.org/10.1016/j.jff.2019.05.015
Arora D, Jaglan S (2017) Therapeutic applications of resveratrol nanoformulations. Environ Chem Lett 16(1):35–41. https://doi.org/10.1007/s10311-017-0660-0
Bacanli M, Dilsiz SA, Başaran N, Başaran AA (2019) Effects of phytochemicals against diabetes. Adv Food Nutr Res 89:209–238. https://doi.org/10.1016/bs.afnr.2019.02.006
Behera A, Mittu B, Padhi S, Patra N, Singh J (2020) Bimetallic nanoparticles: green synthesis, applications, and future perspectives. In: Abd-Elsalam KA (ed) Multifunctional hybrid nanomaterials for sustainable agri-food and ecosystems. Elsevier, Netherland, pp 639–681
Behera A, Padhi S (2020) Passive and active targeting strategies for the delivery of the camptothecin anticancer drug: a review. Environ Chem Lett 18:1557–1567. https://doi.org/10.1007/s10311-020-01022-9
Bhattacharjee N, Barma S, Konwar N, Dewanjee S, Manna P (2016) Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: an update. Eur J Pharmacol 791:8–24. https://doi.org/10.1016/j.ejphar.2016.08.022
Bhuvaneswari S, Anuradha C (2012) Astaxanthin prevents loss of insulin signaling and improves glucose metabolism in liver of insulin resistant mice. Can J Physiol Pharmacol 90:1544–1552. https://doi.org/10.1139/y2012-119
Chockalingam S, Thada R, Dhandapani R, Panchamoorthy R (2015) Biogenesis, characterization, and the effect of vicenin-gold nanoparticles on glucose utilization in 3T3-L1 adipocytes: a bioinformatic approach to illuminate its interaction with PTP 1B and AMPK. Biotechnol Prog 31:1096–1106. https://doi.org/10.1002/btpr.2112
Choi Y, Yoon Y, Choi K, Kwon M, Goo S, Cha J et al (2015) Enhanced oral bioavailability of morin administered in mixed micelle formulation with PluronicF127 and Tween80 in rats. Biol Pharm Bull 38:208–217. https://doi.org/10.1248/bpb.b14-00508
Choudhary A, Kant V, Jangir B, Joshi V (2020) Quercetin loaded chitosan tripolyphosphate nanoparticles accelerated cutaneous wound healing in Wistar rats. Eur J Pharmacol 880:173172. https://doi.org/10.1016/j.ejphar.2020.173172
Chu J, Shi P, Yan W, Fu J, Yang Z, He C et al (2018) PEGylated graphene oxide-mediated quercetin-modified collagen hybrid scaffold for enhancement of MSCs differentiation potential and diabetic wound healing. Nanoscale 10:9547–9560. https://doi.org/10.1039/c8nr02538j
Daisy E, Rajendran N, Houreld N, Marraiki N, Elgorban A, Rajan M (2020) Curcumin and Gymnema sylvestre extract loaded graphene oxide-polyhydroxybutyrate-sodium alginate composite for diabetic wound regeneration. React Funct Polym 154:104671. https://doi.org/10.1016/j.reactfunctpolym.2020.104671
Deshpande A, Harris-Hayes M, Schootman M (2008) Epidemiology of diabetes and diabetes-related complications. Phys Ther 88:1254–1264. https://doi.org/10.2522/ptj.20080020
Devadasu VR, Wadsworth RM, Kumar MR (2011) Protective effects of nanoparticulate coenzyme Q10 and curcumin on inflammatory markers and lipid metabolism in streptozotocin-induced diabetic rats: a possible remedy to diabetic complications. Drug Deliv Transl Res 1:448–455. https://doi.org/10.1007/s13346-011-0041-3
Dewanjee S, Das S, Das A, Bhattacharjee N, Dihingia A, Dua T, Kalita J, Manna P (2018) Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets. Eur J Pharmacol 833:472–523. https://doi.org/10.1016/j.ejphar.2018.06.034
Dong Y, Wan G, Yan P, Qian C, Li F, Peng G (2019) Fabrication of resveratrol coated gold nanoparticles and investigation of their effect on diabetic retinopathy in streptozotocin induced diabetic rats. J Photochem Photobiol B 195:51–57. https://doi.org/10.1016/j.jphotobiol.2019.04.012
Ebrahimpour S, Esmaeili A, Beheshti S (2018) Effect of quercetin-conjugated superparamagnetic iron oxide nanoparticles on diabetes-induced learning and memory impairment in rats. Int J Nanomed 13:6311–6324. https://doi.org/10.2147/ijn.s177871
El-Far Y, Zakaria M, Gabr M, El Gayar A, Eissa L, El-Sherbiny I (2017) Nanoformulated natural therapeutics for management of streptozotocin-induced diabetes: potential use of curcumin nanoformulation. Nanomedicine 12:1689–1711. https://doi.org/10.2217/nnm-2017-0106
El-Far Y, Zakaria M, Gabr M, El Gayar A, El-Sherbiny I, Eissa L (2016) A newly developed silymarin nanoformulation as a potential antidiabetic agent in experimental diabetes. Nanomedicine 11:2581–2602. https://doi.org/10.2217/nnm-2016-0204
Gallelli G, Cione E, Serra R, Leo A, Citraro R, Matricardi P et al (2019) Nano-hydrogel embedded with quercetin and oleic acid as a new formulation in the treatment of diabetic foot ulcer: a pilot study. Int Wound J 17:485–490. https://doi.org/10.1111/iwj.13299
Gokce E, Tuncay Tanrıverdi S, Eroglu I, Tsapis N, Gokce G, Tekmen I et al (2017) Wound healing effects of collagen-laminin dermal matrix impregnated with resveratrol loaded hyaluronic acid-DPPC microparticles in diabetic rats. Eur J Pharm Biopharm 119:17–27. https://doi.org/10.1016/j.ejpb.2017.04.027
Gouda W, Hafiz N, Mageed L, Alazzouni A, Khalil W, Afify M et al (2019) Effects of nano-curcumin on gene expression of insulin and insulin receptor. Bull Natl Res Centre. https://doi.org/10.1186/s42269-019-0164-0
Grama C, Suryanarayana P, Patil M, Raghu G, Balakrishna N, Kumar M et al (2013) Efficacy of biodegradable curcumin nanoparticles in delaying cataract in diabetic rat model. PLoS ONE 8:e78217
Gunasekaran T, Haile T, Nigusse T, Dhanaraju M (2014) Nanotechnology: an effective tool for enhancing bioavailability and bioactivity of phytomedicine. Asian Pac J Trop Biomed 4:S1–S7. https://doi.org/10.12980/apjtb.4.2014c980
Han D, Cho S, Kwak J, Yoon I (2019) Medicinal plants and phytochemicals for diabetes mellitus: pharmacokinetic characteristics and herb-drug interactions. J Pharm Investig 49:603–612. https://doi.org/10.1007/s40005-019-00440-4
Hostetler G, Ralston R, Schwartz S (2017) Flavones: food sources, bioavailability, metabolism, and bioactivity. Adv Nutr Int Rev J 8:423–435. https://doi.org/10.3945/an.116.012948
Hu P, Li Y, Zhou X, Zhang X, Zhang F, Ji L (2018) Association between physical activity and abnormal glucose metabolism—a population-based cross-sectional study in China. J Diabetes Compli 32:746–752. https://doi.org/10.1016/j.jdiacomp.2018.05.021
Jia T, Rao J, Zou L, Zhao S, Yi Z, Wu B et al (2018) Nanoparticle-encapsulated curcumin inhibits diabetic neuropathic pain involving the P2Y12 receptor in the dorsal root ganglia. Front Neurosci 11:755. https://doi.org/10.3389/fnins.2017.00755
Joshi R, Negi G, Kumar A, Pawar Y, Munjal B, Bansal A et al (2013) SNEDDS curcumin formulation leads to enhanced protection from pain and functional deficits associated with diabetic neuropathy: an insight into its mechanism for neuroprotection. Nanomedicine 9:776–785. https://doi.org/10.1016/j.nano.2013.01.001
Kamar S, Abdel-Kader D, Rashed L (2019) Beneficial effect of curcumin nanoparticles-hydrogel on excisional skin wound healing in type-I diabetic rat: histological and immunohistochemical studies. Ann Anat Anatomischer Anzeiger 222:94–102. https://doi.org/10.1016/j.aanat.2018.11.005
Kamaraj N, Rajaguru P, Issac P, Sundaresan S (2017) Fabrication, characterization, in vitro drug release and glucose uptake activity of 14-deoxy, 11, 12-didehydroandrographolide loaded polycaprolactone nanoparticles. Asian J Pharm Sci 12:353–362. https://doi.org/10.1016/j.ajps.2017.02.003
Karri V, Kuppusamy G, Talluri S, Mannemala S, Kollipara R, Wadhwani A et al (2016) Curcumin loaded chitosan nanoparticles impregnated into collagen-alginate scaffolds for diabetic wound healing. Int J Biol Macromol 93:1519–1529. https://doi.org/10.1016/j.ijbiomac.2016.05.038
Kazi KM, Mandal AS, Biswas N, Guha A, Chatterjee S, Behera M et al (2010) Niosome: a future of targeted drug delivery systems. J Adv Pharm Technol Res 1:374–380. https://doi.org/10.4103/0110-5558.76435
Khan M, Aldebasi Y, Alsuhaibani S, AlSahli M, Alzohairy M, Khan A et al (2018) Therapeutic potential of thymoquinone liposomes against the systemic infection of Candida albicans in diabetic mice. PLoS ONE 13:e0208951. https://doi.org/10.1371/journal.pone.0208951
Khan R, Irchhaiya R (2016) Niosomes: a potential tool for novel drug delivery. J Pharm Investig 46:195–204. https://doi.org/10.1007/s40005-016-0249-9
Khoee S, Yaghoobian M (2017) Niosomes: a novel approach in modern drug delivery systems. In: Andronescu E, Grumezescu A (eds) Nanostructures for drug delivery. Elsevier, Amsterdam, pp 207–237. https://doi.org/10.1016/B978-0-323-46143-6.00006-3
Khurana R, Bansal A, Beg S, Burrow A, Katare O, Singh K et al (2017) Enhancing biopharmaceutical attributes of phospholipid complex-loaded nanostructured lipidic carriers of mangiferin: systematic development, characterization and evaluation. Int J Pharm 518:289–306. https://doi.org/10.1016/j.ijpharm.2016.12.044
Khurana R, Gaspar B, Welsby G, Katare O, Singh K, Singh B (2018) Improving the biopharmaceutical attributes of mangiferin using vitamin E-TPGS co-loaded self-assembled phosholipidic nano-mixed micellar systems. Drug Deliv Transl Res 8:617–632. https://doi.org/10.1007/s13346-018-0498-4
Khuroo T, Verma D, Talegaonkar S, Padhi S, Panda A, Iqbal Z (2014) Topotecan–tamoxifen duple PLGA polymeric nanoparticles: investigation of in vitro, in vivo and cellular uptake potential. Int J Pharm 473:384–394. https://doi.org/10.1016/j.ijpharm.2014.07.022
Kwon S, Kim S, Ha K, Kang M, Huh J, Tae Jong I et al (2007) Pharmaceutical evaluation of genistein-loaded pluronic micelles for oral delivery. Arch Pharmacal Res 30:1138–1143. https://doi.org/10.1007/bf02980249
Lamba S, Buch K, Lewis H III, Lamba J (2000) Phytochemicals as potential hypoglycemic agents. Stud Nat Prod Chem 21:457–496. https://doi.org/10.1016/S1572-5995(00)80012-5
Langle A, González-Coronel M, Carmona-Gutiérrez G, Moreno-Rodríguez J, Venegas B, Muñoz G et al (2015) Stevia rebaudiana loaded titanium oxide nanomaterials as an antidiabetic agent in rats. Rev Bras 25:145–151. https://doi.org/10.1016/j.bjp.2015.03.004
Leon B (2015) Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes 6:1246. https://doi.org/10.4239/wjd.v6.i13.1246
Li H, Yao Y, Li L (2017a) Coumarins as potential antidiabetic agents. J Pharm Pharmacol 69:1253–1264. https://doi.org/10.1111/jphp.12774
Li L, Sheng X, Zhao S, Zou L, Han X, Gong Y et al (2017b) Nanoparticle-encapsulated emodin decreases diabetic neuropathic pain probably via a mechanism involving P2X3 receptor in the dorsal root ganglia. Purinerg Signal 13:559–568. https://doi.org/10.1007/s11302-017-9583-2
Li L, Wan X, Zhao G (2014) Meta-analysis of the risk of cataract in type 2 diabetes. BMC Ophthalmol 14:94. https://doi.org/10.1186/1471-2415-14-94
Liu J, Chen Z, Wang J, Li R, Li T, Chang M et al (2018) Encapsulation of curcumin nanoparticles with MMP9-responsive and thermos-sensitive hydrogel improves diabetic wound healing. ACS Appl Mater Interfaces 10:16315–16326
Madureira A, Campos D, Fonte P, Nunes S, Reis F, Gomes A et al (2015) Characterization of solid lipid nanoparticles produced with carnauba wax for rosmarinic acid oral delivery. RSC Adv 5(29):22665–22673. https://doi.org/10.1039/c4ra15802d
Maity S, Mukhopadhyay P, Kundu P, Chakraborti A (2017) Alginate coated chitosan core-shell nanoparticles for efficient oral delivery of naringenin in diabetic animals—an in vitro and in vivo approach. Carbohyd Polym 170:124–132. https://doi.org/10.1016/j.carbpol.2017.04.066
Matzinger M, Fischhuber K, Heiss E (2018) Activation of Nrf2 signaling by natural products-can it alleviate diabetes? Biotechnol Adv 36:1738–1767. https://doi.org/10.1016/j.biotechadv.2017.12.015
McClements D (2010) Design of nano-laminated coatings to control bioavailability of lipophilic food components. J Food Sci 75:R30–R42. https://doi.org/10.1111/j.1750-3841.2009.01452.x
Mohseni R, ArabSadeghabadi Z, Ziamajidi N, Abbasalipourkabir R, RezaeiFarimani A (2019) Oral administration of resveratrol-loaded solid lipid nanoparticle improves insulin resistance through targeting expression of SNARE proteins in adipose and muscle tissue in rats with type II diabetes. Nanoscale Res Lett 14:227. https://doi.org/10.1186/s11671-019-3042-7
Morandi Vuolo M, Silva Lima V, Roberto Maróstica Junior M (2019) Phenolic compounds: structure, classification, and antioxidant power. In: Campos M (ed) Bioactive compounds health benefits and potential applications. Woodhead Publishing, Sawston, pp 33–50
Ni S, Sun R, Zhao G, Xia Q (2014) Quercetin loaded nanostructured lipid carrier for food fortification: preparation, characterization and in vitro study. J Food Process Eng 38:93–106. https://doi.org/10.1111/jfpe.12130
Padhi S, Behera A (2020) Nanotechnology based targeting strategies for the delivery of Camptothecin. In: Saneja A, Panda A, Lichtfouse E (eds) Sustainable agriculture reviews 44. Pharmaceutical technology for natural products delivery, Impact of nanotechnology. Springer, Switzerland, pp 243–272
Padhi S, Kapoor R, Verma D, Panda A, Iqbal Z (2018) Formulation and optimization of topotecan nanoparticles: in vitro characterization, cytotoxicity, cellular uptake and pharmacokinetic outcomes. J Photochem Photobiol B 183:222–232. https://doi.org/10.1016/j.jphotobiol.2018.04.022
Padhi S, Mirza M, Verma D, Khuroo T, Panda A, Talegaonkar S, Khar R, Iqbal Z (2015) Revisiting the nanoformulation design approach for effective delivery of topotecan in its stable form: an appraisal of its in vitro Behavior and tumor amelioration potential. Drug Deliv 23:2827–2837. https://doi.org/10.3109/10717544.2015.1105323
Panwar R, Raghuwanshi N, Srivastava A, Sharma A, Pruthi V (2018) In-vivo sustained release of nanoencapsulated ferulic acid and its impact in induced diabetes. Mater Sci Eng C 92:381–392. https://doi.org/10.1016/j.msec.2018.06.055
Paoli P, Cirri P, Caselli A, Ranaldi F, Bruschi G, Santi A et al (2013) The insulin-mimetic effect of Morin: a promising molecule in diabetes treatment. Biochim Et Biophys Acta (BBA) Gen Subj 1830:3102–3111. https://doi.org/10.1016/j.bbagen.2013.01.017
Papatheodorou K, Banach M, Bekiari E, Rizzo M, Edmonds M (2018) Complications of diabetes 2017. J Diabetes Res 2018:3086167. https://doi.org/10.1155/2018/3086167
Parhi R (2020) Drug delivery applications of chitin and chitosan: a review. Environ Chem Lett 18(3):577–594. https://doi.org/10.1007/s10311-020-00963-5
Piazzini V, Cinci L, D’Ambrosio M, Luceri C, Bilia A, Bergonzi M (2019) Solid lipid nanoparticles and chitosan-coated solid lipid nanoparticles as promising tool for silybin delivery: formulation, characterization, and in vitro evaluation. Curr Drug Deliv 16:142–152. https://doi.org/10.2174/1567201815666181008153602
Pinzón-García A, Cassini-Vieira P, Ribeiro C, de Matos JC, Barcelos L, Cortes M et al (2016) Efficient cutaneous wound healing using bixin-loaded PCL nanofibers in diabetic mice. J Biomed Mater Res B Appl Biomater 105:1938–1949. https://doi.org/10.1002/jbm.b.33724
Ponnappan N, Chugh A (2015) Nanoparticle-mediated delivery of therapeutic drugs. Pharm Med 29:155–167. https://doi.org/10.1007/s40290-015-0096-4
Poornima B, Korrapati P (2017) Fabrication of chitosan-polycaprolactone composite nanofibrous scaffold for simultaneous delivery of ferulic acid and resveratrol. Carbohyd Polym 157:1741–1749. https://doi.org/10.1016/j.carbpol.2016.11.056
Purbowatiningrum N, Ismiyarto FE, Eviana I, Eldiana O et al (2017) Antidiabetic activity from gallic acid encapsulated nanochitosan. IOP Conf Ser Mater Sci Eng 172:012042. https://doi.org/10.1088/1757-899x/172/1/012042
Rani R, Dahiya S, Dhingra D, Dilbaghi N, Kim K, Kumar S (2017) Evaluation of anti-diabetic activity of glycyrrhizin-loaded nanoparticles in nicotinamide-streptozotocin-induced diabetic rats. Eur J Pharm Sci 106:220–230. https://doi.org/10.1016/j.ejps.2017.05.068
Rao M, Manjunath K, Bhagawati S, Thippeswamy B (2014) Bixin loaded solid lipid nanoparticles for enhanced hepatoprotection—Preparation, characterisation and in vivo evaluation. Int J Pharm 473:485–492. https://doi.org/10.1016/j.ijpharm.2014.07.027
Raslan M, Mohamed S, Abd El Maksoud M, El Nesr K (2018) Role of curcumin-zinc oxide composite nanoparticles on streptozotocin-induced diabetic rats. J Biotechnol 8:55. https://doi.org/10.4172/2155-952X-C6-103
Reis F, Madureira A, Nunes S, Campos D, Fernandes J, Marques C et al (2016) Safety profile of solid lipid nanoparticles loaded with rosmarinic acid for oral use: in vitro and animal approaches. Int J Nanomed 11:3621–3640. https://doi.org/10.2147/ijn.s104623
Saka R, Chella N (2020) Nanotechnology for delivery of natural therapeutic substances: a review. Environ Chem Lett 19(2):1097–1106. https://doi.org/10.1007/s10311-020-01103-9
Salehi B, Ata A, Anil Kumar VN, Sharopov F, Ramírez-Alarcón K, Ruiz-Ortega A et al (2019) Antidiabetic potential of medicinal plants and their active components. Biomolecules 9:551. https://doi.org/10.3390/biom9100551
Samadian H, Zamiri S, Ehterami A, Farzamfar S, Vaez A, Khastar H et al (2020) Electrospun cellulose acetate/gelatin nanofibrous wound dressing containing berberine for diabetic foot ulcer healing: in vitro and in vivo studies. Sci Rep 10:8312. https://doi.org/10.1038/s41598-020-65268-7
Sharma P, Saxena P, Jaswanth A, Chalamaiah M, Balasubramaniam A (2017) Antidiabetic activity of lycopene niosomes: experimental observation. J Pharm Drug Dev 4:1. https://doi.org/10.15744/2348-9782.4.103
Tang L, Li K, Zhang Y, Li H, Li A, Xu Y et al (2020) Quercetin liposomes ameliorate streptozotocin-induced diabetic nephropathy in diabetic rats. Sci Rep 10:2440. https://doi.org/10.1038/s41598-020-59411-7
Tong F, Liu S, Yan B, Li X, Ruan S, Yang S (2017) Quercetin nanoparticle complex attenuated diabetic nephropathy via regulating the expression level of ICAM-1 on endothelium. Int J Nanomed 12:7799–7813. https://doi.org/10.2147/ijn.s146978
Verma D, Thakur P, Padhi S, Khuroo T, Talegaonkar S, Iqbal Z (2017) Design expert assisted nanoformulation design for co-delivery of topotecan and thymoquinone: optimization, in vitro characterization and stability assessment. J Mol Liq 242:382–394. https://doi.org/10.1016/j.molliq.2017.07.002
Vitak T, Yurkiv B, Wasser S, Nevo E, Sybirna N (2017) Effect of medicinal mushrooms on blood cells under conditions of diabetes mellitus. World J Diabetes 8:187. https://doi.org/10.4239/wjd.v8.i5.187
Wang G, Li Q, Chen D, Wu B, Wu Y, Tong W et al (2019) Kidney-targeted rhein-loaded liponanoparticles for diabetic nephropathy therapy via size control and enhancement of renal cellular uptake. Theranostics 9:6191–6208. https://doi.org/10.7150/thno.37538
Wang J, Tan J, Luo J, Huang P, Zhou W, Chen L et al (2017) Enhancement of scutellarin oral delivery efficacy by vitamin B12-modified amphiphilic chitosan derivatives to treat type II diabetes induced-retinopathy. J Nanobiotechnol 15:18. https://doi.org/10.1186/s12951-017-0251-z
Wang S, Du S, Wang W, Zhang F (2020) Therapeutic investigation of quercetin nanomedicine in a zebrafish model of diabetic retinopathy. Biomed Pharmacother 130:110573. https://doi.org/10.1016/j.biopha.2020.110573
Wang T, Wang N, Song H, Xi X, Wang J, Hao A et al (2011) Preparation of an anhydrous reverse micelle delivery system to enhance oral bioavailability and anti-diabetic efficacy of berberine. Eur J Pharm Sci 44:127–135. https://doi.org/10.1016/j.ejps.2011.06.015
Wang Z, Wu J, Zhou Q, Wang Y, Chen T (2015) Berberine nanosuspension enhances hypoglycemic efficacy on streptozotocin induced diabetic C57BL/6 Mice. Evid-Based Complement Altern Med 2015:1–5. https://doi.org/10.1155/2015/239749
Wani TU, Raza SN, Khan NA (2019) Rosmarinic acid loaded chitosan nanoparticles for wound healing in rats. Int J Pharm Sci Res 10:1126–1135. https://doi.org/10.13040/IJPSR.0975-8232
Wu B, Liang Y, Tan Y, Xie C, Shen J, Zhang M et al (2016) Genistein-loaded nanoparticles of star-shaped diblock copolymer mannitol-core PLGA–TPGS for the treatment of liver cancer. Mater Sci Eng C 59:792–800. https://doi.org/10.1016/j.msec.2015.10.087
Xu X, Shi F, Wei Z, Zhao Y (2016) Nanostructured lipid carriers loaded with baicalin: an efficient carrier for enhanced antidiabetic effects. Pharmacogn Mag 12:198. https://doi.org/10.4103/0973-1296.186347
Xue M, Yang M, Zhang W, Li X, Gao D, Ou Z et al (2013) Characterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticles. Int J Nanomed 2013:4677. https://doi.org/10.2147/ijn.s51262
Xue M, Zhang L, Yang M, Zhang W, Li X, Ou Z et al (2015) Berberine-loaded solid lipid nanoparticles are concentrated in the liver and ameliorate hepatosteatosis in db/db mice. Int J Nanomed 10:5049–5057. https://doi.org/10.2147/ijn.s84565
Yin J, Hou Y, Yin Y, Song X (2017) Selenium-coated nanostructured lipid carriers used for oral delivery of berberine to accomplish a synergic hypoglycemic effect. Int J Nanomed 12:8671–8680. https://doi.org/10.2147/ijn.s144615
Yücel Ç, Karatoprak G, Aktaş Y (2018) Nanoliposomal resveratrol as a novel approach to treatment of diabetes mellitus. J Nanosci Nanotechnol 18:3856–3864. https://doi.org/10.1166/jnn.2018.15247
Zhang P, He L, Zhang J, Mei X, Zhang Y, Tian H et al (2020) Preparation of novel berberine nano-colloids for improving wound healing of diabetic rats by acting Sirt1/NF-κB pathway. Colloids Surf B 187:110647. https://doi.org/10.1016/j.colsurfb.2019.110647
Zhang Y, Li Z, Zhang K, Yang G, Wang Z, Zhao J et al (2016) Ethyl oleate-containing nanostructured lipid carriers improve oral bioavailability of trans -ferulic acid ascompared with conventional solid lipid nanoparticles. Int J Pharm 511:57–64. https://doi.org/10.1016/j.ijpharm.2016.06.131
Zhang Z, Cui C, Wei F, Lv H (2017) Improved solubility and oral bioavailability of apigenin via Soluplus/Pluronic F127 binary mixed micelles system. Drug Dev Ind Pharm 43:1276–1282. https://doi.org/10.1080/03639045.2017.1313857
Funding
The authors do not have any funding sources for preparation of the review article.
Author information
Authors and Affiliations
Contributions
All the authors equally contributed for preparation of the review paper.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Padhi, S., Dash, M. & Behera, A. Nanophytochemicals for the treatment of type II diabetes mellitus: a review. Environ Chem Lett 19, 4349–4373 (2021). https://doi.org/10.1007/s10311-021-01283-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10311-021-01283-y